accountBreaking down Pfizer's earnings numbers, which beat EPS estimates, but fell short on revenue, with Seamus Fernandez, pharma analyst, Leerink Swann, pharma analyst. Also looking at pharma's best stock picks...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Q1 Earnings Results Mixed
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account